Healthcare Triangle
HCTI
1 hedge funds and large institutions have $27.2K invested in Healthcare Triangle in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
30% less capital invested
Capital invested by funds: $39K → $27.2K (-$11.8K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $19.4K | – | – | – |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $7.69K | – | – | – |
|
3
Wells Fargo
San Francisco,
California
| $22 | – | – | – |
|
4
Bank of America
Charlotte,
North Carolina
| $13 | – | – | – |
|
5
JP Morgan Chase
New York
| $2 | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$1.88K | – | – |
|
HCTI Hedge Fund Activity: Q1 2024 in Review
1 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Healthcare Triangle (HCTI) for Q1 2024, worth a combined $27.2K — down 30% from $39K a quarter earlier.
Fund positioning in HCTI was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was UBS Group, cutting an estimated $1.88K.
- 1 institutional investor held Healthcare Triangle (HCTI) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $27.2K of Healthcare Triangle stock for Q1 2024, down 30% quarter-over-quarter.
- 0 funds opened new Healthcare Triangle positions in Q1 2024 and 0 closed out.
- The largest Healthcare Triangle seller in Q1 2024 was UBS Group, an estimated $1.88K sold.
Based on aggregated 13F filings for Q1 2024.